Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor

Cancer immunotherapy including adoptive T cell therapy (ACT) is widely used in the clinic and is highly beneficial for patients with hematological malignancies; however, it remains a challenge to develop effective immunotherapy strategies for the treatment of solid cancers, due to the inefficiency o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qingzhi, Zhang, Chi, Wang, Huilan, Peng, Tao, Zhang, Li, Wang, Yang, Han, Weidong, Shi, Chunmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861368/
https://www.ncbi.nlm.nih.gov/pubmed/31781498
http://dx.doi.org/10.3389/fonc.2019.01196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861368/
https://www.ncbi.nlm.nih.gov/pubmed/31781498
http://dx.doi.org/10.3389/fonc.2019.01196

Ejemplares similares